Especifique uma ação ou criptomoeda na barra de pesquisa para obter um resumo
United Laboratories International Holdings Ltd
3933The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, amoxicillin products, nervous system drugs, vitamins, veterinary drugs, and vacant gelatin capsules. It also provides intermediate products, such as 6-aminopenicillanic acid, tert-octylammonium clavulanate, anhydrous sodium carbonate sterile, and penicillin G potassium first crystal. In addition, the company manufactures and sells soft capsules casings; holds trademarks; and trades in pharmaceutical products, as well as offers management services. It has operations in the People's Republic of China, India, Europe, the Middle East, South America, rest of Asian regions, and internationally. The company was founded in 1990 and is headquartered in Yuen Long, Hong Kong. Address: 6 Fuk Wang Street, Yuen Long, Hong Kong
Analytics
Preço Alvo de Wall Street
90.93 HKDRácio P/E
5.8613Rendimento de dividendos
7.47 %Ano atual
Ano passado
Trimestre Atual
Ultimo quarto
Ano atual
Ano passado
Trimestre Atual
Ultimo quarto
Figuras chave 3933
Análise de Dividendos 3933
Crescimento de dividendos em 5 anos
363 %Crescimento contínuo
5 anosTaxa de pagamento em média de 5 anos
20 %Histórico de Dividendos 3933
Avaliação de ações 3933
Relatório 3933
Acompanhe as principais métricas de cada ação em um só lugar, sem complicações
Inscreva-se no premiumResultados | 2019 | Dinâmica |